April 8, 2015
- Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes-a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study will add to the knowledge of the use of GLP-1 receptor agonists in people with type 1 diabetes.
- Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
- Perinatal and childhood risk factors for early-onset type 1 diabetes: a population-based case-control study in Taiwan.
- Lower serum 25 (OH) D concentrations in type 1 diabetes: A meta-analysis.
